German image-guided surgery developer BrainLab said the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has ruled in its favor regarding a patent infringement suit filed by competitor Nomos of Cranberry Township, PA.
The court upheld a lower-court ruling that BrainLab’s ExacTrac product did not infringe on U.S. patent 5,411,026, which Nomos holds for its BAT ultrasound-based target-locating device.
ExacTrac is BrainLab’s patient-positioning system for tumor treatment using stereotactic radiotherapy/radiosurgery.
By AuntMinnie.com staff writersFebruary 10, 2004
Related Reading
BrainLab, Rad Technology ink deal, October 20, 2003
BrainLab gets FDA nod, August 19, 2003
BrainLab moves into Asia, June 23, 2003
BrainLab lands first BrainSuite sale, May 1, 2003
BrainLab inks supply deal with US Oncology, February 4, 2003
Copyright © 2004 AuntMinnie.com
